Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients

Indian Journal of Pediatrics

Volumn 78, Issue 6, 2011, Pages 679-683

  Merchant, Rashid H ^a,b   Shirodkar, Amruta ^a   Ahmed, Javed ^a  

^a DR BALABHAI NANAVATI HOSPITAL   (India)

^b 501 Rang Mahal Society   (India)

Author keywords

Delayed puberty; Hypogonadism; Hypoparathyroidism; Hypothyroidism; Multitransfused thalassemia; Short stature

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PARATHYROID HORMONE; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENDOCRINE DISEASE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH DISORDER; HUMAN; HYPOGONADISM; INDIAN; IRON OVERLOAD; IRON STORAGE; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY AMENORRHEA; PUBERTY; PUBERTY DISORDERS; SEXUAL MATURITY; SHORT STATURE; TESTOSTERONE BLOOD LEVEL; THALASSEMIA MAJOR; THYROTROPIN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADOLESCENT; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; ENDOCRINE SYSTEM DISEASES; FEMALE; FERRITINS; GROWTH DISORDERS; HUMANS; INDIA; IRON OVERLOAD; MALE; PUBERTY; THALASSEMIA; YOUNG ADULT;

EID: 79958276399     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-010-0351-3     Document Type: Article

References (28)

1. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Complications of β-thalassemia major in North America. Blood. 2004;104:34-9.
2. Aydinok Y, Darcan S, Polat A, et al. Endocrine complications in patients with β-thalassemia major. J Trop Pediatr. 2002;48:50-4.
3. Lo L, Singer ST. Thalassemia: Current approach to an old disease. Pediatr Clin North Am. 2002;49:1165-91.
4. Borgna-Pignatti C, De Stefano P, Zonta L, et al. Growth and sexual maturation in thalassemia major. J Pediatr. 1985;106:150-5.
5. Low LC. Growth of children with beta-thalassemia major. Indian J Pediatr. 2005;72:159-64.
6. Kattamis C, Liakopoulou T, Kattamis A. Growth and development in children with thalassaemia major. Acta Paediatr Scand Suppl. 1990;366:111-7.
7. Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997;10:175-84.
8. George A, Bhaduri A, Sen S, Choudhry VP. Physical growth parameters in thalassemic children. Indian J Pediatr. 1997;64:861-71.
9. De Virgiliis S, Cossu P, Toccafondi C, et al. Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients. Am J Pediatr Hematol Oncol. 1983;5:73-7.
10. Fargion S, Taddei MT, Gabutti V, et al. Early iron overload in beta-thalassaemia major: when to start chelation therapy? Arch Dis Child. 1982;57:929-33.
11. Wu KH, Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol. 2003;82:637-40.
12. Karydis I. Karagiorga-Lagana M, Nounopoulos C, Tolis G. Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in beta-thalassemia major. J Pediatr Endocrinol Metab. 2004;17:17-25.
13. Low LC, Postel-Vinay MC, Kwan EY, Cheung PT. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment. Clin Endocrinol (Oxf). 1998;48:641-6.
14. Ghosh S, Bandyopadhyay SK, Bandyopadhyay R, Roy D, Maisnam I, Ghosh MK. A study on endocrine dysfunction in thalassaemia. J Indian Med Assoc. 2008;106:655-9.
15. Flynn DM, Hoffbrand AV, Politis D. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography. Birth Defects Orig Artic Ser. 1982;18:347-53.
16. Agarwal MB, Shah S, Vishwanathan C, et al. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr. 1992;29:997-1002.
17. Hader A, Bashir N, Hasan Z, Khatib S. Thyroid function in children with beta-thalassemia major in north Jordan. J Trop Pediatr. 1993;39:107-10.
18. Cavallo L, Licci D, Acquafredda A, et al. Endocrine involvement in children with beta-thalassaemia major. Transverse and longitudinal studies. I. Pituitary-thyroidal axis function and its correlation with serum ferritin levels. Acta Endocrinol (Copenh). 1984;107:49-53.
19. Filosa A, Di Maio S, Aloj G, Acampora C. Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab. 2006;19:1397-404.
20. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000;13:651-6.
21. Italian Working Group on Endocrine Complications in Non-Endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol (Oxf). 1995;42:581-6.
22. Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol. 2002;24:291-3.
23. Srivatsa A, Marwaha RK, Muralidharan R. Trehan A. Assessment of Adrenal Endocrine Function in Asian Thalassemics: Indian Pediatrics. 2005;42:31-5.
24. Tyagi S, Kabra M, Tandon N, Saxena R, Pati H, Choudhry VP. linico haematological profile of thalassemia Intermedia patients. Int. J Hum Genet. 2003;3:251-8.
25. Jain M, Sinha RS, Chellani H, Anand NK. Assessment of thyroid functions and its role in body growth in thalassemia major. Indian Pediatr. 1995;32:213-9.
26. Agarwal MB. Deferasirox: oral, once daily iron chelator-an expert opinion. Indian J Pediatr. 2010;77:185-91.
27. Agarwal MB. Advances in management of thalassemia. Indian J Pediatr. 2009;76:177-84.
28. Choudhry VP, Naithani R. Current status of iron overload and chelation with deferasirox. Indian J Pediatr. 2007;74:759-64.